Screener
Candel Therapeutics, Inc. CADL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
FAQ
- What is Candel Therapeutics, Inc.'s enterprise value?
- Candel Therapeutics, Inc. (CADL) reported enterprise value of $166.92M in Q1 2026.
- How has Candel Therapeutics, Inc.'s enterprise value changed year-over-year?
- Candel Therapeutics, Inc.'s enterprise value decreased by 10.1% year-over-year, from $185.63M to $166.92M.
- What is the long-term trend for Candel Therapeutics, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Candel Therapeutics, Inc.'s enterprise value has grown at a 8.0% compound annual growth rate (CAGR), from $142.28M to $193.36M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Candel Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude